Enhancing oral vaccine potency by targeting intestinal M cells, PLoS Pathogens, vol.6, 2010. ,
Tissue-specific differences in immune cell subsets located in the naso-oropharyngeal-associated lymphoid tissues, Scand. J. Immunol, vol.87, pp.15-27, 2018. ,
Single bilayer liposomes prepared without sonication, Biochim. Biophys. Acta, vol.298, pp.1015-1019, 1973. ,
Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles, J. Control. Release, vol.232, pp.42-50, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01595080
Nasal nanovaccines, Int. J. Pharm, vol.530, pp.128-138, 2017. ,
Inducing mucosal IgA: a challenge for vaccine adjuvants and delivery systems, J. Immunol, vol.199, pp.9-16, 2017. ,
Porous maltodextrinbased nanoparticles: a safe delivery system for nasal vaccines, J. Nanomater, 2018. ,
Improved alpha-chymotrypsin stability upon encapsulation in PLGA microspheres by solvent replacement, Pharm. Res, vol.20, pp.1873-1880, 2003. ,
Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier, Int. J. Pharm, vol.379, pp.285-292, 2009. ,
Delivery of a peptide via poly(D, L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cellstimulatory capacity, Nanomed. Nanotechnol. Biol. Med, vol.6, pp.651-661, 2010. ,
Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer, BMC Biotechnol, vol.2, p.9, 2002. ,
Nanoparticles for nasal vaccination, Adv. Drug Deliv. Rev, vol.61, pp.140-157, 2009. ,
PLGA-based nanoparticles: an overview of biomedical applications, J. Control. Release, vol.161, pp.505-522, 2012. ,
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines, J. Nanobiotechnol, vol.15, p.83, 2017. ,
Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic Toxoplasma gondii infection, Biomaterials, vol.50, pp.164-175, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01190168
Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses, J. Drug Target, vol.11, pp.495-507, 2003. ,
Influence of surface charge and inner composition of nanoparticles on intracellular delivery of proteins in airway epithelial cells, Biomaterials, vol.33, pp.9117-9126, 2012. ,
Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice, Future Microbiol, vol.12, pp.393-405, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01608412
Novel vaccine development strategies for inducing mucosal immunity, Expert Rev. Vac, vol.11, pp.367-379, 2012. ,
Chemical coupling of thiolated chitosan to preformed liposomes improves mucoadhesive properties, Int. J. Nanomed, vol.7, pp.2523-2534, 2012. ,
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro, Int. J. Pharm, vol.344, pp.103-109, 2007. ,
Macrophages on the nasal mucosal surface in provoked and naturally occurring allergic rhinitis, Acta Otolaryngol, vol.111, pp.946-953, 1991. ,
6-Mercaptopurine reduces cytokine and Muc5ac expression involving inhibition of NFkappaB activation in airway epithelial cells, Respir. Res, vol.16, p.73, 2015. ,
Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells, Int. J. Pharm, vol.454, pp.712-719, 2013. ,
Residence time and uptake of porous and cationic maltodextrin-based nanoparticles in the nasal mucosa: comparison with anionic and cationic nanoparticles, Int. J. Pharm, vol.550, pp.316-324, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02628930
Formulation and characterization of antigen-loaded PLGA nanoparticles for efficient cross-priming of the antigen, Immune Netw, vol.11, pp.163-168, 2011. ,
Intranasal delivery of nanoparticle-based vaccines, Therap. Deliv, vol.8, pp.151-167, 2017. ,
Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables, Drug Deliv, vol.15, pp.267-275, 2008. ,
Vaccination strategies for mucosal immune responses, Clin. Microbiol. Rev, vol.14, pp.430-445, 2001. ,
, International Journal of Pharmaceutics: X, vol.1, p.100001, 2019.
Endocytosis and exocytosis of nanoparticles in mammalian cells, Int. J. Nanomed, vol.9, pp.51-63, 2014. ,
Nanostructures for protein drug delivery, Biomater. Sci, vol.4, pp.205-218, 2016. ,
Positively-charged, porous, polysaccharide nanoparticles loaded with anionic molecules behave as 'stealth' cationic nanocarriers, Pharm. Res, vol.27, pp.126-133, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00491864
Novel methods for liposome preparation, Chem. Phys. Lipids, vol.177, pp.8-18, 2014. ,
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy, Nanomed. Nanotechnol. Biol. Med, vol.7, pp.1-10, 2011. ,
Innate cell communication kickstarts pathogen-specific immunity, Nat. Immunol, vol.17, pp.356-363, 2016. ,
A novel CD4-CD8alpha+CD205+CD11b-murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis, Cell. Microbiol, vol.7, pp.1659-1671, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02680845
Development of novel cationic chitosan-and anionic alginate-coated poly(D, Llactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol, Int. J. Nanomed, vol.7, pp.5501-5516, 2012. ,
Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells, Mol. Pharm, vol.4, pp.47-57, 2007. ,
Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine, Mol. Pharm, vol.8, pp.405-415, 2011. ,
Recent advances with liposomes as pharmaceutical carriers, Nat. Rev. Drug Discov, vol.4, pp.145-160, 2005. ,
Protein instability in poly(lactic-coglycolic acid) microparticles, Pharm. Res, vol.17, pp.1159-1167, 2000. ,
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens, Vaccine, vol.30, pp.2256-2272, 2012. ,
Control of local immunity by airway epithelial cells, Mucosal Immunol, vol.9, pp.287-298, 2016. ,
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment, Int. J. Pharm, vol.419, pp.52-59, 2011. ,
Recruitment of bone marrow CD11b(+)Gr-1(+) cells by polymeric nanoparticles for antigen cross-presentation, Sci. Rep, vol.7, p.44691, 2017. ,
Strategies for intranasal delivery of vaccines, Drug Deliv. Transl. Res, vol.3, pp.100-109, 2013. ,
Nanoparticle vaccines, Vaccine, vol.32, pp.327-337, 2014. ,
, International Journal of Pharmaceutics: X, vol.1, p.100001, 2019.